The mechanical development of a novel pulsed transdermal therapeutic system (TTS) is described in this proposal. The TTS will utilize Intelimer TM polymeric membranes, proprietary to Landec Labs., and a thermal signal generator to drive them. Because the membranes have a very low permeability to a variety of drugs below a """"""""switch temperature"""""""" and a very high permeability above that temperature, the release of a drug can activated and controlled by a small heat stimulus to change the state of the membrane. The system has potential for many dosing regimens. Benefits derived from such a system include the reduction of tolerance, improved patient compliance, and patient controlled therapy. This proposal focused on the development of a system to provide the heat stimulus required to activate the Intelimer TM membrane. The research will encompass a review of heating technologies appropriate to this concept. A prototype using the most appropriate heating method will be constructed using the Intelimer TM polymers. This prototype will be evaluated with respect to response time, temperature control, and other parameters. Finally, the thermal heating prototype will be laminated into a transdermal device complete with a drug reservoir. The release profile of a drug as it responds to the heat stimulus will be monitored in vitro.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43GM046156-01
Application #
3498637
Study Section
Special Emphasis Panel (SSS (B1))
Project Start
1991-07-01
Project End
1992-01-31
Budget Start
1991-07-01
Budget End
1992-01-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Landec Corporation
Department
Type
DUNS #
City
Menlo Park
State
CA
Country
United States
Zip Code
94025